BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 8099935)

  • 1. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional sites on the A alpha-chain. Polymorphic residues involved in antigen presentation to insulin-specific, Ab alpha:Ak beta-restricted T cells.
    Reske-Kunz AB; Landais D; Peccoud J; Benoist C; Mathis D
    J Immunol; 1989 Sep; 143(5):1472-81. PubMed ID: 2474599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
    Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
    J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for peptide in alloreactive CD4+ T cell recognition of class II MHC molecules.
    Weber DA; Terrell NK; Zhang Y; Strindberg G; Martin J; Rudensky A; Braunstein NS
    J Immunol; 1995 May; 154(10):5153-64. PubMed ID: 7730621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ class I-restricted T cells specific for HIV gp160 315-329.
    Moore RL; Fox BS
    Cell Immunol; 1994 Mar; 154(1):43-53. PubMed ID: 7907008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th cells and Th2 responses can develop in the absence of MHC class II-CD4 interactions.
    Wack A; Corbella P; Harker N; Roderick K; Norton T; Williams K; Williams O; Kioussis D
    J Immunol; 1999 Aug; 163(3):1162-9. PubMed ID: 10415010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
    Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
    J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor recognition of MHC class II alloantigens is highly cell type dependent.
    Katz JF; Sant AJ
    J Immunol; 1994 Feb; 152(4):1629-40. PubMed ID: 7907104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD4 can confer major histocompatibility complex class II-associated superantigen reactivity upon a T cell receptor derived from a CD8-dependent cytotoxic T lymphocyte clone.
    Wallace VA; Ohashi PS; Hengartner H; Mak TW
    Eur J Immunol; 1990 Nov; 20(11):2471-7. PubMed ID: 2123792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anti-mouse xenorecognition. Provision of noncognate interactions reveals plasticity of T cell repertoire.
    Batten P; Heaton T; Fuller-Espie S; Lechler RI
    J Immunol; 1995 Aug; 155(3):1057-65. PubMed ID: 7543511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
    Yelon D; Schaefer KL; Berg LJ
    J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones.
    Gotoh Y; Takashima H; Noguchi K; Nishimura H; Tokushima M; Shirai T; Kimoto M
    J Immunol; 1993 Jun; 150(11):4777-87. PubMed ID: 8496588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.
    Harton JA; Bishop GA
    J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.